Literature DB >> 31093765

Progression of vascular changes in macular telangiectasia type 2: comparison between SD-OCT and OCT angiography.

Daniel Pauleikhoff1,2, Frederic Gunnemann3, Marius Book3, Kai Rothaus3.   

Abstract

PURPOSE: To investigate the different appearances of vascular changes in macular telangiectasia type 2 (MacTel) and to describe their possible progression, the vascular patterns in different retinal layers were analyzed with optical coherence tomography angiography (OCT-A) and the findings were correlated with a spectral-domain OCT (SD-OCT) disease severity scale based on the extent of ellipsoid zone (EZ) loss.
METHODS: Participants from the MacTel Study Group in Muenster and a healthy cohort were investigated with OCT-A using RTVue XR Avanti. After segmentation of the superficial capillary network, the deep capillary network, and the outer retina (OR), flow density was analyzed using Optovue software. Then, the images were exported using the software Fiji (National Institute of Mental Health, Bethesda, MD, USA) and analyzed with the automated MATLAB program (Mathworks, Version R2014b). Four parameters (total vessel length, number of vessel branches, number of vessel segments, and fractal dimension) were examined on the vascular skeletons (temporal, foveal, nasal, and total fields of the ETDRS grid). In addition, linear and area measurements of EZ loss were performed on SD-OCT volume scans. Progression characteristics and correlation between linear and area measurements were analyzed using linear mixed effects models.
RESULTS: Twenty eyes of healthy probands (20 OCT-A and 20 SD-OCT scans) and 122 eyes of 61 MacTel patients were included. In order to classify the severity of the disease, MacTel eyes were assigned to a SD-OCT "disease severity scale" (grade 1 = no EZ loss; grade 2 = EZ loss temporal to the fovea; grade 3 = EZ loss including the fovea and the region nasal to the fovea). Flow density and total vessel length showed only limited differences between healthy eyes and different grades of MacTel, but particularly the numbers of branches and vessel segments, as well as the fractal dimension values, demonstrated significant and progressive reduction in the superficial and deep capillary networks of the temporal, nasal, and total ETDRS fields. Moreover, the outer retina showed a progressive presence of hyperreflective material in SD-OCT grades 2 and 3 eyes with associated vascular patterns in the OR on OCT-A.
CONCLUSIONS: In SD-OCT, the severity of MacTel is characterized by progressive EZ loss, which may be used as a simple clinical "disease severity scale". In addition, OCT-A enables visualization and quantification of vascular patterns with mathematical methods. The morphological progression of the disease correlated significantly with progressive vascular changes, especially in respect of the numbers of branches and vessel segments as well as fractal dimension. This suggests that the severity of neurodegenerative and neurovascular changes develops in parallel and that the analysis and quantification of the vascular changes in the superficial and deep capillary networks may become an additional parameter for future treatment trials. Moreover, the significant association between hyperreflective material progressively visible on SD-OCT in the OR, which most often contains vessels in OCT-A, and advancing SD-OCT severity grades, as well as vascular changes in OCT-A, supports the concept of retinal neovascularization in the OR in patients with advanced MacTel.

Entities:  

Keywords:  Disease severity scale; MacTel; Macular telangiectasia type 2; OCT; OCT angiography; Vascular changes

Mesh:

Year:  2019        PMID: 31093765     DOI: 10.1007/s00417-019-04323-0

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  10 in total

1.  One-year follow-up of optical coherence tomography angiography microvascular findings: macular telangiectasia type 2 versus tamoxifen retinopathy.

Authors:  Yu Jeong Park; Suhwan Lee; Young Hee Yoon
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2022-05-10       Impact factor: 3.535

2.  [Influence of CNV vascular morphology in exudative age-related macular degeneration on development of visual acuity and need for anti-VEGF therapy after 1 year].

Authors:  Henrik Faatz; Marie-Louise Gunnemann; Kai Rothaus; Marius Book; Matthias Gutfleisch; Albrecht Lommatzsch; Daniel Pauleikhoff
Journal:  Ophthalmologe       Date:  2021-02       Impact factor: 1.059

Review 3.  Imaging endpoints for clinical trials in MacTel type 2.

Authors:  Daniel Pauleikhoff; Laurenz Pauleikhoff; Emily Y Chew
Journal:  Eye (Lond)       Date:  2021-08-13       Impact factor: 3.775

4.  Early-stage macular telangiectasia type 2 vascular abnormalities are associated with interdigitation zone disruption.

Authors:  Janice X Ong; Roya Zandi; Amani A Fawzi
Journal:  PLoS One       Date:  2021-11-12       Impact factor: 3.240

5.  Does size of telangiectasia on optical coherence tomography angiography influence vision in eyes with type 2 macular telangiectasia?

Authors:  Aditya S Kelkar; Jai A Kelkar; Sayali Tidke; Aanchal Agarwal; Mounika Bolisetty; Shreekant Kelkar
Journal:  Indian J Ophthalmol       Date:  2021-12       Impact factor: 1.848

6.  Commentary: Imaging in macular telangiectasia type 2 - Correlating structural change with vision.

Authors:  Muna Bhende
Journal:  Indian J Ophthalmol       Date:  2021-12       Impact factor: 1.848

Review 7.  Macular Telangiectasia Type 2: A Comprehensive Review.

Authors:  Kiran Chandra Kedarisetti; Raja Narayanan; Michael W Stewart; Nikitha Reddy Gurram; Arshad M Khanani
Journal:  Clin Ophthalmol       Date:  2022-10-10

8.  Changes in the OCT angiographic appearance of type 1 and type 2 CNV in exudative AMD during anti-VEGF treatment.

Authors:  Henrik Faatz; Marie-Louise Farecki; Kai Rothaus; Matthias Gutfleisch; Daniel Pauleikhoff; Albrecht Lommatzsch
Journal:  BMJ Open Ophthalmol       Date:  2019-12-10

9.  Overlap between telangiectasia and photoreceptor loss increases with progression of macular telangiectasia type 2.

Authors:  Paul S Micevych; Hee Eun Lee; Amani A Fawzi
Journal:  PLoS One       Date:  2019-10-28       Impact factor: 3.240

10.  Vascular Analysis of Type 1, 2, and 3 Macular Neovascularization in Age-Related Macular Degeneration Using Swept-Source Optical Coherence Tomography Angiography Shows New Insights into Differences of Pathologic Vasculature and May Lead to a More Personalized Understanding.

Authors:  Henrik Faatz; Kai Rothaus; Martin Ziegler; Marius Book; Britta Heimes-Bussmann; Daniel Pauleikhoff; Albrecht Lommatzsch
Journal:  Biomedicines       Date:  2022-03-17
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.